$TMO News

Thermo Fisher closes $1.1B sale of microbiology unit to PE firm

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

Thermo Fisher Says India Is One Of Its Fastest-Growing Markets

Witnessing An Insider Decision, Joseph R Holmes Exercises Options Valued At $120K At Thermo Fisher Scientific

How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects

Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?

How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends

Thermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat

The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call

Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600

Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650

Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026

Thermo Fisher Scientific's Strong Q2 Not Enough to 'Meaningfully' Change H2 Outlook, RBC Says

TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves